Wolverine Trading
IBRX icon

Wolverine Trading’s ImmunityBio IBRX Stock Holding History

Wolverine Trading’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$369K Buy
143,600
+22,200
+18% +$57.2K ﹤0.01% 4072
2025
Q2 		$328K Buy
121,400
+32,400
+36% +$87.1K ﹤0.01% 3386
2025
Q1 		$279K Sell
89,000
-6,300
-7% -$19.1K ﹤0.01% 3600
2024
Q4 		$255K Buy
95,300
+23,700
+33% +$98.7K ﹤0.01% 4214
2024
Q3 		$281K Buy
+71,600
New +$331K ﹤0.01% 3700
2024
Q2 		– Sell
-44,700
Closed -$240K – 4813
2024
Q1 		$240K Buy
44,700
+19,000
+74% +$86K ﹤0.01% 3594
2023
Q4 		$129K Buy
25,700
+1,700
+7% +$5.33K ﹤0.01% 4037
2023
Q3 		$40.6K Sell
24,000
-10,400
-30% -$20.9K ﹤0.01% 4223
2023
Q2 		$93.6K Sell
34,400
-11,100
-24% -$31.4K ﹤0.01% 3794
2023
Q1 		$80K Sell
45,500
-31,500
-41% -$97.9K ﹤0.01% 3719
2022
Q4 		$390K Sell
77,000
-10,900
-12% -$59.9K ﹤0.01% 2548
2022
Q3 		$434K Buy
87,900
+64,600
+277% +$294K ﹤0.01% 2765
2022
Q2 		$88K Sell
23,300
-9,700
-29% -$39K ﹤0.01% 3884
2022
Q1 		$194K Buy
33,000
+1,100
+3% +$6.75K ﹤0.01% 4454
2021
Q4 		$204K Buy
+31,900
New +$240K ﹤0.01% 4683
2021
Q3 		– Sell
-26,200
Closed -$381K – 6548
2021
Q2 		$381K Sell
26,200
-2,700
-9% -$44.6K ﹤0.01% 4087
2021
Q1 		$686K Buy
28,900
+4,500
+18% +$117K ﹤0.01% 3259
2020
Q4 		$350K Sell
24,400
-29,900
-55% -$288K ﹤0.01% 3571
2020
Q3 		$390K Buy
+54,300
New +$541K ﹤0.01% 3080
2020
Q2 		– Sell
-26,900
Closed -$84K – 4853
2020
Q1 		$84K Buy
+26,900
New +$135K ﹤0.01% 4090

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wolverine Trading's IBRX Position: Q3 2025 in Review

Wolverine Trading increased its ImmunityBio (IBRX) stake by 39% in Q3 2025, buying an estimated $22.8K and bringing the position to 31,631 shares worth $81.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5276.

Wolverine Trading first reported a position in IBRX in Q4 2019 and has held it in 9 quarters since. The position peaked at $870K in Q1 2021. 264 funds tracked by Wall St. Rank hold IBRX as of Q3 2025.

  • Wolverine Trading held 31,631 shares of ImmunityBio worth $81.3K as of Q3 2025.
  • Wolverine Trading bought 8,838 ImmunityBio shares in Q3 2025, an estimated $22.8K.
  • ImmunityBio made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5276 holding.
  • Wolverine Trading first reported a position in ImmunityBio in Q4 2019 and has held it in 9 quarters since.
  • Wolverine Trading's ImmunityBio position peaked at $870K in Q1 2021.
  • 264 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.